60. 再生不良性貧血 Aplastic anemia Clinical trials / Disease details

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03318159 (ClinicalTrials.gov)	April 20, 2018	10/10/2017	Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients	Open Label, Phase II Study Investigating the Efficacy of Posaconazoleas Prophylaxis Antifungal Agent ...	Aplastic Anemia;Myelodysplastic Syndromes;Fungal Infection	Drug: Posaconazole	Seoul National University Hospital	Merck Sharp & Dohme Corp.	Unknown status	18 Years	75 Years	All	40	Phase 2	Korea, Republic of
2	NCT02875743 (ClinicalTrials.gov)	December 7, 2016	18/8/2016	King's Invasive Aspergillosis Study II	Incidence of Invasive Fungal Disease in Patients Receiving Immunosuppressive Therapy, Intensive Chem ...	Aplastic Anemia;Leukemia, Myeloid, Acute;Myelodysplastic Syndromes;Bone Marrow Transplantation	Drug: Posaconazole	King's College Hospital NHS Trust	NULL	Completed	18 Years	N/A	All	120	Phase 4	United Kingdom
3	EUCTR2016-001223-31-GB (EUCTR)	11/10/2016	07/09/2016	Incidence of Invasive Fungal Disease in Patients receiving Immunosuppressive Therapy, Intensive Chem ...	Incidence of Invasive Fungal Disease in Patients receiving Immunosuppressive Therapy, Intensive Chem ...	Aplastic Anaemia, Myelodysplastic syndromes, Acute Myeloid Leukaemia undergoing immunosuppression th ...	Trade Name: Noxafil ® Product Name: Noxafil Gastro resistant tablets	King's College Hospital NHS Foundation Trust	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 4	United Kingdom

First Previous1Next Last